Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Osteoporosis is a skeletal disorder characterised by low bone mass and microarchitectural deterioration of bone tissue with a consequent increase in the fragility of bone and consequent susceptibility to fracture. The fractures most commonly reported are those of the proximal femur, distal radius and vertebra, but fractures at other sites such as the pelvis, proximal humerus, and proximal tibia, also show similar patterns. These fractures are the serious and important outcomes of the condition and lead to severe mortality and morbidity, a significant burden on society in general and a huge impact economically. Fracture rates vary by age and geography; absolute numbers are expected to rise in subsequent generations despite stabilisation of fracture rates due to demographic population changes. Clustering of fractures is commonly described and may help in the identification of those individuals at highest risk who would benefit most from therapy. This chapter will review the epidemiology of fragility fractures, and highlight the importance of fracture at a personal and societal level.

Original publication

DOI

10.1007/978-3-030-78128-6_1

Type

Book title

Osteoporosis Treatment: A Clinical Overview

Publication Date

16/08/2021

Pages

1 - 16